SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-14-350208
Filing Date
2014-09-23
Accepted
2014-09-23 17:00:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d793424dsc13d.htm SC 13D 32007
  Complete submission text file 0001193125-14-350208.txt   33391
Mailing Address FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076
Business Address
VENKATARAMAN BALAJI (Filed by) CIK: 0001114916 (see all company filings)

Type: SC 13D

Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Subject) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86365 | Film No.: 141116522
SIC: 2834 Pharmaceutical Preparations